Jefferies Group's DNTH Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 202,410 shares of Dianthus Therapeutics, Inc. (DNTH) worth $16.99 M, representing 0.12% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Jefferies Group has maintained this position in DNTH for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 202,410 shares. Largest reduction occurred in Q2 2024, reducing 7,600 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Dianthus Therapeutics (DNTH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Dianthus Therapeutics (DNTH) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +202,410 | New Buy | 202,410 | $83.92 |
| Q2 2024 | -7,600 | Sold Out | 0 | $0.00 |
| Q1 2024 | -5,600 | Reduce 42.42% | 7,600 | $30.00 |
| Q3 2023 | +13,200 | New Buy | 13,200 | $13.67 |
Jefferies Group's Dianthus Therapeutics Investment FAQs
Jefferies Group first purchased Dianthus Therapeutics, Inc. (DNTH) in Q3 2023, acquiring 13,200 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Dianthus Therapeutics, Inc. (DNTH) for 5 quarters since Q3 2023.
Jefferies Group's largest addition to Dianthus Therapeutics, Inc. (DNTH) was in Q1 2026, adding 202,410 shares worth $16.99 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 202,410 shares of Dianthus Therapeutics, Inc. (DNTH), valued at approximately $16.99 M.
As of the Q1 2026 filing, Dianthus Therapeutics, Inc. (DNTH) represents approximately 0.12% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Dianthus Therapeutics, Inc. (DNTH) was 202,410 shares, as reported at the end of Q1 2026.